The Board has remanded the case due to insufficient development of evidence regarding the cause of the Veteran's death, specifically his monoclonal gammopathy.
The deciding factor: The Board found that additional development is needed to determine if the Veteran's monoclonal gammopathy contributed substantially or materially to his death.
- Claimed conditions
- Monoclonal gammopathy
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 1, 2023
- Citation
- 23059037
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 23059037.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board has remanded the case due to insufficient development of evidence regarding the cause of the Veteran's death, specifically whether his hypertensive heart disease and diastolic heart failure are related to in-service toxic exposures and whether they contributed substantially or materially to his death.
- Denied
The Board denied a compensable rating for the Veteran's service-connected monoclonal gammopathy, finding that the condition is stable with no associated symptoms or impairment.
- Denied
The Board denied service connection for monoclonal gammopathy and hypertension, as well as a psychiatric disability other than the already-service connected depressive disorder (PTSD), and an initial compensable rating for bilateral hearing loss.
- Denied
The Board denied the Veteran's claims of service connection for peripheral neuropathy of the bilateral upper and lower extremities, as well as monoclonal gammopathy. The Board found that there was no evidence to support a direct link between these conditions and the Veteran's military service or exposure to herbicide agents.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.